Anzalone Christopher Richard's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Mar 5, 2025
- Accession no.
- 0001628280-25-010672
- Filed
- Mar 5, 2025
- Trade date
- Mar 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.27M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anzalone Christopher RichardCIK 0001423029 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | MOption exerciseAcquired | +166,667 | $7.75 | +$1,291,669.25 | 3,940,469 | Direct | |
| Mar 4, 2025 | Common Stock | MOption exerciseAcquired | +133,333 | $7.75 | +$1,033,330.75 | 4,073,802 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −166,667 | $18.03 | −$3,005,006.01 | 3,907,135 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −133,333 | $17.02 | −$2,269,327.66 | 3,773,802 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | MOption exerciseDisposed | −166,667 | $0.00 | $0 | 185,059 | Direct | |
| Mar 3, 2025 | Common Stock | MOption exerciseDisposed | −133,333 | $0.00 | $0 | 51,726 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.